Short-Term Administration of Pegvisomant Improves Hepatic Insulin Sensitivity and Reduces Soleus Muscle Intramyocellular Lipid Content in Young Adults With Type 1 Diabetes (Q58811115)
Jump to navigation
Jump to search
scientific article published on 11 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-Term Administration of Pegvisomant Improves Hepatic Insulin Sensitivity and Reduces Soleus Muscle Intramyocellular Lipid Content in Young Adults With Type 1 Diabetes |
scientific article published on 11 December 2013 |
Statements
Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes (English)
A Thankamony
P H Tossavainen
D Elleri
R N Dalton
N C Jackson
A M Umpleby
11 December 2013